Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Insights, Forecast to 2028
Table of Contents1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 BMS-906024
1.2.3 Buparlisib Hydrochloride
1.2.4 FP-1039
1.2.5 Ipilimumab
1.2.6 JNJ-42756493
1.2.7 Lenvatinib
1.2.8 Others
1.3 Market by Application
1.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Perspective (2017-2028)
2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Growth Trends by Region
2.2.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Market Dynamics
2.3.1 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Trends
2.3.2 Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers
2.3.3 Squamous Non-Small Cell Lung Cancer Therapeutics Market Challenges
2.3.4 Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue
3.1.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
3.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2021
3.5 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Type
4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2023-2028)
5 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Application
5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
6.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
6.2.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
6.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
6.3.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
6.4 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
6.4.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
7.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
7.2.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
7.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
7.3.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
7.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
7.4.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
9.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
9.2.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
9.3.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
9.4.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ascenta Therapeutics, Inc.
11.1.1 Ascenta Therapeutics, Inc. Company Details
11.1.2 Ascenta Therapeutics, Inc. Business Overview
11.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.1.4 Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.1.5 Ascenta Therapeutics, Inc. Recent Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.2.4 AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.2.5 AstraZeneca Plc Recent Developments
11.3 AVEO Pharmaceuticals, Inc.
11.3.1 AVEO Pharmaceuticals, Inc. Company Details
11.3.2 AVEO Pharmaceuticals, Inc. Business Overview
11.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.3.4 AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.3.5 AVEO Pharmaceuticals, Inc. Recent Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.4.4 Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.4.5 Bayer AG Recent Developments
11.5 BIND Therapeutics, Inc.
11.5.1 BIND Therapeutics, Inc. Company Details
11.5.2 BIND Therapeutics, Inc. Business Overview
11.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.5.4 BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.5.5 BIND Therapeutics, Inc. Recent Developments
11.6 Boehringer Ingelheim GmbH
11.6.1 Boehringer Ingelheim GmbH Company Details
11.6.2 Boehringer Ingelheim GmbH Business Overview
11.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.6.4 Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.6.5 Boehringer Ingelheim GmbH Recent Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.7.5 Bristol-Myers Squibb Company Recent Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.8.4 Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.8.5 Eli Lilly and Company Recent Developments
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Company Details
11.9.2 F. Hoffmann-La Roche Ltd. Business Overview
11.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.9.4 F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.9.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.10 Five Prime Therapeutics, Inc.
11.10.1 Five Prime Therapeutics, Inc. Company Details
11.10.2 Five Prime Therapeutics, Inc. Business Overview
11.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.10.4 Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.10.5 Five Prime Therapeutics, Inc. Recent Developments
11.11 Genentech, Inc.
11.11.1 Genentech, Inc. Company Details
11.11.2 Genentech, Inc. Business Overview
11.11.3 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.11.4 Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.11.5 Genentech, Inc. Recent Developments
11.12 Incyte Corporation
11.12.1 Incyte Corporation Company Details
11.12.2 Incyte Corporation Business Overview
11.12.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.12.4 Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.12.5 Incyte Corporation Recent Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.13.4 Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.13.5 Johnson & Johnson Recent Developments
11.14 MacroGenics, Inc.
11.14.1 MacroGenics, Inc. Company Details
11.14.2 MacroGenics, Inc. Business Overview
11.14.3 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.14.4 MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.14.5 MacroGenics, Inc. Recent Developments
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.15.4 Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.15.5 Novartis AG Recent Developments
11.16 Oncogenex Pharmaceuticals, Inc.
11.16.1 Oncogenex Pharmaceuticals, Inc. Company Details
11.16.2 Oncogenex Pharmaceuticals, Inc. Business Overview
11.16.3 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.16.4 Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.16.5 Oncogenex Pharmaceuticals, Inc. Recent Developments
11.17 PsiOxus Therapeutics Limited
11.17.1 PsiOxus Therapeutics Limited Company Details
11.17.2 PsiOxus Therapeutics Limited Business Overview
11.17.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.17.4 PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
11.17.5 PsiOxus Therapeutics Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of TablesTable 1. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of BMS-906024
Table 3. Key Players of Buparlisib Hydrochloride
Table 4. Key Players of FP-1039
Table 5. Key Players of Ipilimumab
Table 6. Key Players of JNJ-42756493
Table 7. Key Players of Lenvatinib
Table 8. Key Players of Others
Table 9. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Region (2017-2022)
Table 13. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Region (2023-2028)
Table 15. Squamous Non-Small Cell Lung Cancer Therapeutics Market Trends
Table 16. Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers
Table 17. Squamous Non-Small Cell Lung Cancer Therapeutics Market Challenges
Table 18. Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints
Table 19. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share by Players (2017-2022)
Table 21. Global Top Squamous Non-Small Cell Lung Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics as of 2021)
Table 22. Ranking of Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service
Table 26. Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2017-2022)
Table 30. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2023-2028)
Table 32. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share by Application (2017-2022)
Table 34. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share by Application (2023-2028)
Table 36. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 66. Ascenta Therapeutics, Inc. Company Details
Table 67. Ascenta Therapeutics, Inc. Business Overview
Table 68. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 69. Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Ascenta Therapeutics, Inc. Recent Developments
Table 71. AstraZeneca Plc Company Details
Table 72. AstraZeneca Plc Business Overview
Table 73. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 74. AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 75. AstraZeneca Plc Recent Developments
Table 76. AVEO Pharmaceuticals, Inc. Company Details
Table 77. AVEO Pharmaceuticals, Inc. Business Overview
Table 78. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 79. AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 80. AVEO Pharmaceuticals, Inc. Recent Developments
Table 81. Bayer AG Company Details
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 84. Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 85. Bayer AG Recent Developments
Table 86. BIND Therapeutics, Inc. Company Details
Table 87. BIND Therapeutics, Inc. Business Overview
Table 88. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 89. BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 90. BIND Therapeutics, Inc. Recent Developments
Table 91. Boehringer Ingelheim GmbH Company Details
Table 92. Boehringer Ingelheim GmbH Business Overview
Table 93. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 94. Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 95. Boehringer Ingelheim GmbH Recent Developments
Table 96. Bristol-Myers Squibb Company Company Details
Table 97. Bristol-Myers Squibb Company Business Overview
Table 98. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 99. Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 100. Bristol-Myers Squibb Company Recent Developments
Table 101. Eli Lilly and Company Company Details
Table 102. Eli Lilly and Company Business Overview
Table 103. Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 104. Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 105. Eli Lilly and Company Recent Developments
Table 106. F. Hoffmann-La Roche Ltd. Company Details
Table 107. F. Hoffmann-La Roche Ltd. Business Overview
Table 108. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 109. F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 110. F. Hoffmann-La Roche Ltd. Recent Developments
Table 111. Five Prime Therapeutics, Inc. Company Details
Table 112. Five Prime Therapeutics, Inc. Business Overview
Table 113. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 114. Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 115. Five Prime Therapeutics, Inc. Recent Developments
Table 116. Genentech, Inc. Company Details
Table 117. Genentech, Inc. Business Overview
Table 118. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 119. Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 120. Genentech, Inc. Recent Developments
Table 121. Incyte Corporation Company Details
Table 122. Incyte Corporation Business Overview
Table 123. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 124. Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 125. Incyte Corporation Recent Developments
Table 126. Johnson & Johnson Company Details
Table 127. Johnson & Johnson Business Overview
Table 128. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 129. Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 130. Johnson & Johnson Recent Developments
Table 131. MacroGenics, Inc. Company Details
Table 132. MacroGenics, Inc. Business Overview
Table 133. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 134. MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 135. MacroGenics, Inc. Recent Developments
Table 136. Novartis AG Company Details
Table 137. Novartis AG Business Overview
Table 138. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 139. Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 140. Novartis AG Recent Developments
Table 141. Oncogenex Pharmaceuticals, Inc. Company Details
Table 142. Oncogenex Pharmaceuticals, Inc. Business Overview
Table 143. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 144. Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 145. Oncogenex Pharmaceuticals, Inc. Recent Developments
Table 146. PsiOxus Therapeutics Limited Company Details
Table 147. PsiOxus Therapeutics Limited Business Overview
Table 148. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 149. PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 150. PsiOxus Therapeutics Limited Recent Developments
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. BMS-906024 Features
Figure 3. Buparlisib Hydrochloride Features
Figure 4. FP-1039 Features
Figure 5. Ipilimumab Features
Figure 6. JNJ-42756493 Features
Figure 7. Lenvatinib Features
Figure 8. Others Features
Figure 9. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2021 VS 2028
Figure 10. Research Center Case Studies
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies